Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

C1galt1-deficient mice exhibit thrombocytopenia due to abnormal terminal differentiation of megakaryocytes

Takashi Kudo, Takashi Sato, Kozue Hagiwara, Yukinori Kozuma, Takashi Yamaguchi, Yuzuru Ikehara, Michito Hamada, Ken Matsumoto, Masatsugu Ema, Soichiro Murata, Nobuhiro Ohkohchi, Hisashi Narimatsu, Satoru Takahashi

Blood (2013) 122 (9): 1649–1657.

https://doi.org/10.1182/blood-2012-12-471102

Published: 2013

Journal Articles

Phospho-Specific Flow Cytometry of Fixed Whole Blood During AML Clinical Trials to Monitor In Vivo FLT3 Inhibition in Leukemic Blasts,

Alexander E Perl, MD, Grace R Jeschke, Takashi Sato, Shiro Akinaga, Niranjan S. Rao, PhD, Maria R. Baer, MD, Mark J. Levis, MD, PhD, Martin Carroll, MD

Blood (2011) 118 (21): 3508.

https://doi.org/10.1182/blood.V118.21.3508.3508

Published: 2011

Journal Articles

FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo

Takashi Sato, Xiaochuan Yang, Steven Knapper, Paul White, B. Douglas Smith, Steven Galkin, Donald Small, Alan Burnett, Mark Levis

Blood (2011) 117 (12): 3286–3293.

https://doi.org/10.1182/blood-2010-01-266742

Published: 2011

Journal Articles

Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse

Blood (2011) 117 (12): 3294–3301.

https://doi.org/10.1182/blood-2010-08-301796

Published: 2011

Journal Articles

Early Phase Administration of Hematopoietic Stem Cell Transplantation to Prevent Early Relapse for Infants with Acute Lymphoblastic Leukemia and MLL Gene Rearrangement; a Report From the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Trial MLL03

Katsuyoshi Koh, MD, Daisuke Tomizawa, MD, Akiko Moriya Saito, MD, PhD, Tomoyuki Watanabe, PhD, Atsushi Ogawa, MD, Takashi Sato, MD, Masahiro Hirayama, MD, Yoshihiro Takahashi, MD, Yutaka Saikawa, MD, PhD, Takako Miyamura, MD, Koji Kato, MD, PhD, Kanji Sugita, MD, PhD, Takeyuki Sato, MD, Tomohiko Taki, MD, PhD, Shuki Mizutani, MD, PhD, Masahito Tsurusawa, MD, Keizo Horibe, MD, Eiichi Ishii, MD, PhD

Blood (2010) 116 (21): 529.

https://doi.org/10.1182/blood.V116.21.529.529

Published: 2010

Journal Articles

The Impact of ABO Major Incompatibility In Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning.

Kazuhiro Nakamura, MD, Aya Kamata, MD, Mizuka Miki, MD, Teruyuki Kajiume, MD, Yasuhiko Sera, MD, Takashi Sato, MD, Masao Kobayashi, MD

Blood (2010) 116 (21): 4520.

https://doi.org/10.1182/blood.V116.21.4520.4520

Published: 2010

Journal Articles

Nation-Wide Survey of Relapsed Infantile Acute Lymphoblastic Leukemia In Japan: Treatment and Outcome From the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) MLL03 Study.

Takako Miyamura, MD, PhD, Katsuyoshi Koh, MD, Daisuke Tomizawa, MD, Takashi Sato, MD, PhD, Koji Kato, MD, PhD, Kanji Sugita, MD, PhD, Masahiro Hirayama, MD, Atsushi Ogawa, MD, Yoshihiro Takahashi, MD, Ryosei Nishimura, MD, PhD, Hidemasa Ochiai, MD, Yuko Nomura, MD, Akiko Saito, MD, PhD, Masahito Tsurusawa, MD, PhD, Keizo Horibe, MD, PhD, Eiichi Ishii, MD, PhD

Blood (2010) 116 (21): 1025.

https://doi.org/10.1182/blood.V116.21.1025.1025

Published: 2010

Journal Articles

FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML

Keith W. Pratz, Takashi Sato, Kathleen M. Murphy, Adam Stine, Trivikram Rajkhowa, Mark Levis

Blood (2010) 115 (7): 1425–1432.

https://doi.org/10.1182/blood-2009-09-242859

Published: 2010

Journal Articles

FLT3 Mutant to Wild Type Allelic Ratio and Clinical Status Are Predictive of Response to FLT3 Inhibitors in AML.

Mark Levis, Takashi Sato, Kathleen Murphy, Trivikram Rajkhowa, Keith Pratz

Blood (2009) 114 (22): 1716.

https://doi.org/10.1182/blood.V114.22.1716.1716

Published: 2009

Journal Articles

Hematopoietic Stem Cell Transplantation with Reduced Intensity Regimens in Patients with Severe Congenital Neutropenia without Malignant Transformation.

Yoshiyuki Kobayashi, MD, Kazuhiro Nakamura, MD, Takashi Sato, MD, Masao Kobayashi, MD, PhD

Blood (2009) 114 (22): 1355.

https://doi.org/10.1182/blood.V114.22.1355.1355

Published: 2009

Journal Articles

Increased Plasma FLT3 Ligand Levels Following Chemotherapy May Interfere with the Clinical Efficacy of FLT3 Inhibitors.

Takashi Sato, Steven Knapper, Alan K Burnett, Paul White, Mark Levis

Blood (2009) 114 (22): 937.

https://doi.org/10.1182/blood.V114.22.937.937

Published: 2009

Journal Articles

Results From a Randomized Trial of Salvage Chemotherapy Followed by Lestaurtinib for FLT3 Mutant AML Patients in First Relapse.

Blood (2009) 114 (22): 788.

https://doi.org/10.1182/blood.V114.22.788.788

Published: 2009

Journal Articles

Effective Hematopoietic Stem Cell Transplantation with Reduced Intensity Conditioning for Patients with Chronic Granulomatous Disease.

Yoko Mizoguchi, MD, Mizuka Miki, MD, Teruyuki Kajiume, MD, Hiroshi Kawaguchi, MD, Kazuhiro Nakamura, MD, Takashi Sato, MD, Masao Kobayashi, MD, PhD

Blood (2009) 114 (22): 3339.

https://doi.org/10.1182/blood.V114.22.3339.3339

Published: 2009

Journal Articles

Clinical Characteristics in Neonates with Alloimmune Neutropenia: Significance of the Detection of Antineutrophil Antibodies

Yoko Mizoguchi, MD, Kazuhiro Nakamura, MD, Shuhei Karakawa, MD, Takashi Sato, MD, Rie Onodera, Emi Kurita, Asako Hiraoka, Kikuyo Taniguchi, Masao Kobayashi, MD, PhD

Blood (2008) 112 (11): 4647.

https://doi.org/10.1182/blood.V112.11.4647.4647

Published: 2008

Journal Articles

Short-Term Culture of Umbilical Cord Blood-Derived Stem Cells Enhances the Engraftment into NOD/SCID Mice through the Increased Expression of CXCR4.

Norioki Ohno, MD, Teruyuki Kajiume, MD, PhD, Yoshihiko Sera, MD, PhD, Takashi Sato, MD, PhD, Masao Kobayashi, MD, PhD

Blood (2008) 112 (11): 1721.

https://doi.org/10.1182/blood.V112.11.1721.1721

Published: 2008

Journal Articles

Reconstitution of Regulatory T Cells Involves in the Development of Acute Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation.

Shuhei Karakawa, MD, Kazuhiro Nakamura, MD, Keiichi Hara, MD, Yoko Mizoguchi, MD, Mizuka Miki, MD, Hiroshi Kawaguchi, MD, Takashi Sato, MD, Shin-ichiro Nishimura, MD, Masao Kobayashi, MD, PhD

Blood (2008) 112 (11): 2204.

https://doi.org/10.1182/blood.V112.11.2204.2204

Published: 2008

Journal Articles

Nation-Wide Survey of Infant Leukemia in Japan: A Report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG).

Takako Miyamura, MD. PhD, Katsuyoshi Koh, MD. PhD, Daisuke Tomizawa, MD, Kanji Sugita, MD. PhD, Koji Kato, MD. PhD, Takashi Sato, MD. PhD, Yoshihiro Takahashi, MD. PhD, Atsushi Ogawa, MD. PhD, Masahiro Hirayama, MD. PhD, Akira Kikuchi, MD. PhD, Megumi Oda, MD. PhD, Daiichiro Hasegawa, MD. PhD, Kazutoshi Koike, MD. PhD, Yutaka Saikawa, MD. PhD, Michiki Hatanaka, MD. PhD, Keizo Horibe, MD. PhD, Eiichi Ishii, MD. PhD

Blood (2008) 112 (11): 896.

https://doi.org/10.1182/blood.V112.11.896.896

Published: 2008

Journal Articles

The Decrease of Regulatory T Cells through the Low Levels of FOXP3 Expression Mediated by NFAT1 in Infancy with Autoimmune Neutropenia.

Kazuhiro Nakamura, MD, Mizuka Miki, MD, Syuhei Karakawa, MD, Rie Onodera, Emi Kurita, Asako Hiraoka, Takashi Sato, MD, Masao Kobayashi, MD

Blood (2007) 110 (11): 666.

https://doi.org/10.1182/blood.V110.11.666.666

Published: 2007

Journal Articles

The Expression of Polycomb Group Genes Products, Bmi1 and Mel-18, Regulate the Function of Murine Primitive Hematopoietic Cells.

Teruyuki Kajiume, Takashi Sato, Masao Kobayashi

Blood (2007) 110 (11): 1261.

https://doi.org/10.1182/blood.V110.11.1261.1261

Published: 2007

Journal Articles

Successful Bone Marrow Transplantation with an Intensively Immunosuppressive Conditioning with Low Toxicity for High-Risk Chronic Granulomatous Disease Patients.

Mizuka Miki, MD, Teruyuki Kajiume, M.D., Kazuhiro Nakamura, M.D., Hiroshi Kawaguchi, M.D., Takashi Sato, M.D., Emi Kurita, Rie Onodera, Asako Hiraoka, Tomoyuki Mizukami, M.D., Hiroyuki Nunoi, M.D., Masao Kobayashi, M.D.

Blood (2006) 108 (11): 5354.

https://doi.org/10.1182/blood.V108.11.5354.5354

Published: 2006

NARROW

C1galt1-deficient mice exhibit thrombocytopenia due to abnormal terminal differentiation of megakaryocytes

Phospho-Specific Flow Cytometry of Fixed Whole Blood During AML Clinical Trials to Monitor In Vivo FLT3 Inhibition in Leukemic Blasts,

FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo

Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse

Early Phase Administration of Hematopoietic Stem Cell Transplantation to Prevent Early Relapse for Infants with Acute Lymphoblastic Leukemia and MLL Gene Rearrangement; a Report From the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Trial MLL03

The Impact of ABO Major Incompatibility In Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning.

Nation-Wide Survey of Relapsed Infantile Acute Lymphoblastic Leukemia In Japan: Treatment and Outcome From the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) MLL03 Study.

FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML

FLT3 Mutant to Wild Type Allelic Ratio and Clinical Status Are Predictive of Response to FLT3 Inhibitors in AML.

Hematopoietic Stem Cell Transplantation with Reduced Intensity Regimens in Patients with Severe Congenital Neutropenia without Malignant Transformation.

Increased Plasma FLT3 Ligand Levels Following Chemotherapy May Interfere with the Clinical Efficacy of FLT3 Inhibitors.

Results From a Randomized Trial of Salvage Chemotherapy Followed by Lestaurtinib for FLT3 Mutant AML Patients in First Relapse.

Effective Hematopoietic Stem Cell Transplantation with Reduced Intensity Conditioning for Patients with Chronic Granulomatous Disease.

Clinical Characteristics in Neonates with Alloimmune Neutropenia: Significance of the Detection of Antineutrophil Antibodies

Short-Term Culture of Umbilical Cord Blood-Derived Stem Cells Enhances the Engraftment into NOD/SCID Mice through the Increased Expression of CXCR4.

Reconstitution of Regulatory T Cells Involves in the Development of Acute Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation.

Nation-Wide Survey of Infant Leukemia in Japan: A Report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG).

The Decrease of Regulatory T Cells through the Low Levels of FOXP3 Expression Mediated by NFAT1 in Infancy with Autoimmune Neutropenia.

The Expression of Polycomb Group Genes Products, Bmi1 and Mel-18, Regulate the Function of Murine Primitive Hematopoietic Cells.

Successful Bone Marrow Transplantation with an Intensively Immunosuppressive Conditioning with Low Toxicity for High-Risk Chronic Granulomatous Disease Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only